DUSA announces court ruling halts sale of generic Nicomide by River's Edge

By Elaine Rigoli

Tampa, Fla., May 15 - DUSA Pharmaceuticals, Inc. announced Monday that the U.S. District Court in Trenton, N.J., issued a preliminary injunction against River's Edge Pharmaceuticals LLC enjoining the company from selling its niacinamide formula drug as a generic substitute for Nicomide, a patented product of DUSA.

In issuing the injunction, which will be effective as soon as DUSA posts a bond or cash in lieu thereof, the court ordered that River's Edge must cease importing, making, having made, using, selling and/or offering to sell its product.

River's Edge also must immediately recall and remove from the stream of commerce its product and request the removal of the listing of its product as a substitute from the National Drug Data File maintained by First DataBank.

Based in Wilmington, Mass., DUSA is an integrated dermatology specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.